Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa

NCT00213005 is registered in ClinicalTrials.gov with Population Council as lead sponsor.

NCT NCT00213005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00213005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa
Lead sponsor
Population Council
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2002
Completion date
August 31, 2003
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections